Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cyclezyme ABXSAT:CYCLE -2.05%8 PB Ratio is 8.95 as of Jul. 14, 2026, which is 35% above its 10-year median of 6.65. GuruFocus rates XSAT:CYCLE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 1,575 Chemicals companies, Cyclezyme AB ranks worse than 93.52% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-14), Cyclezyme AB's share price is kr23.90. Cyclezyme AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr2.67. Hence, Cyclezyme AB's PB Ratio of today is 8.95.
Warning Sign:
Cyclezyme AB stock PB Ratio (=9.14) is close to 2-year high of 9.88.
The historical rank and industry rank for Cyclezyme AB's PB Ratio or its related term are showing as below:
XSAT:CYCLE'
s PB Ratio Range Over the Past 10 Years
Min: 4.51 Med: 6.65 Max: 9.88
Current: 8.95
During the past 6 years, Cyclezyme AB's highest PB Ratio was 9.88. The lowest was 4.51. And the median was 6.65.
XSAT:CYCLE's PB Ratio is ranked worse than 93.52% of 1575
companies
in the Chemicals industry
Industry Median: 1.69
vs XSAT:CYCLE: 8.95
During the past 12 months, Cyclezyme AB's average Book Value Per Share Growth Rate was 30.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 57.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 190.20% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Cyclezyme AB was 544.60% per year. The lowest was 57.00% per year. And the median was 150.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Cyclezyme AB PB Ratio Related Terms
Cyclezyme AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Cyclezyme AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Cyclezyme AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclezyme AB PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cyclezyme AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cyclezyme AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Cyclezyme AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Cyclezyme AB (XSAT:CYCLE) has a PB Ratio of 8.95 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cyclezyme AB and its competitors. This is 35% above median its historical median of 6.65. Over the past decade, Cyclezyme AB's PB Ratio has ranged from 4.51 to 9.88. According to the industry distribution chart, Cyclezyme AB ranks #1473 out of 1575 companies in the Chemicals industry, placing it in the top 93.5%.
Is Cyclezyme AB's PB Ratio too high?
Cyclezyme AB's current PB Ratio of 8.95 is 35% above median its 10-year median of 6.65. Over the past 10 years, this metric has ranged from a low of 4.51 to a high of 9.88. The Chemicals industry median PB Ratio is 1.69. Cyclezyme AB's value of 8.95 is 429.6% above this industry median. Based on the distribution chart, Cyclezyme AB ranks #1473 out of 1575 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's PB Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Cyclezyme AB ranks #1473 out of 1575 companies for PB Ratio. This places Cyclezyme AB in the lower half of its industry. The industry median PB Ratio is 1.69. Cyclezyme AB's value of 8.95 is 429.6% above this benchmark. Historically, Cyclezyme AB's own PB Ratio has ranged from 4.51 to 9.88 over the past decade. While the company's 10-year median is 6.65 vs. the industry median of 1.69, Cyclezyme AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.69, based on 1,575 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cyclezyme AB's current PB Ratio of 8.95 is 429.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cyclezyme AB and its competitors. For the Chemicals industry, the median PB Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyclezyme AB's current PB Ratio is 8.95, which is 35% above median its own 10-year median of 6.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current PB Ratio of 8.95. The current PB Ratio is 8.95, which is 35% above median its 10-year median of 6.65 and 429.6% above the Chemicals industry median of 1.69. Cyclezyme AB's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current PB Ratio is 8.95 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score
Get the complete analysis for XSAT:CYCLE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CYCLE has been successfully added to your 
